Browsing by Author "Hernandez, G"
Now showing 1 - 4 of 4
Results Per Page
Sort Options
- ItemGut mucosal atrophy after a short enteral pasting period in critically ill patients(1999) Hernandez, G; Velasco, N; Wainstein, C; Castillo, L; Bugedo, G; Maiz, A; Lopez, F; Guzman, S; Vargas, CPurpose: The purpose of this study was to evaluate the presence of gut mucosal atrophy and changes in mucosal permeability in critically ill patients after a short fasting period.
- ItemInfluence of polymeric enteral nutrition supplemented with different doses of glutamine on gut permeability in critically ill patients(2001) Velasco, N; Hernandez, G; Wainstein, C; Castillo, L; Maiz, A; Lopez, F; Guzman, S; Bugedo, G; Acosta, AM; Bruhn, AOBJECTIVES: To evaluate the effect of glutamine-supplemented polymeric enteral formulas on the recovery of gut-permeability abnormalities in critically ill patients.
- ItemManagement of septic shock with a norepinephrine-based haemodynamic algorithm(ELSEVIER IRELAND LTD, 2005) Hernandez, G; Bruhn, A; Romero, C; Larrondo, FJ; De La Fuente, R; Castillo, L; Bugedo, GManagement of septic shock (SS) with a norepinephrine (noradrenaline)-based haemodynamic algorithm. Introduction: The choice of the best vasopressor for haemodynamic management of septic shock is controversial. Nevertheless, very few studies have been focused on evaluating different management algorithms. The aim of this study was to evaluate the performance of a norepinephrine (NE)-based management protocol. Experience with NE as the initial vasopressor, even if not comparative, could bring relevant data for planning future trails. We also wanted to evaluate the compliance of critical care physicians and nurses with haemodynamic management protocol.
- ItemUse of methylene blue in patients with refractory septic shock: Impact on hemodynamics and gas exchange(W B SAUNDERS CO, 1998) Andresen, M; Dougnac, A; Diaz, O; Hernandez, G; Castillo, L; Bugedo, G; Alvarez, M; Dagnino, JPurpose: The purpose of this study was to assess the acute effects of methylene blue, an inhibitor of nitric oxide synthesis, on hemodynamics and gas exchange in patients with refractory septic shock in a prospective clinical trial at medical and surgical intensive care units in a tertiary university hospital.
